cerebral hemorrhage

To date, there's been four small randomized studies and an aggregate meta-analysis of these studies encompassing a total of 660 participants has not demonstrated clear net benefit of anticoagulation versus anticoagulation avoidance.

We conducted ENRICH-AF globally at 240 sites in 20 countries.

The trial randomized patients with intracranial hemorrhage and atrial fibrillation with a CHAS vascor of two or more to either receive standard dosing of doxaban, 60 milligrams daily, dose adjusted to 30 milligrams daily, or non-anticoagulant medical therapy, which could have included single antiplatelet therapy at the clinician's discretion.

Ultimately, 944 patients were included in our analysis, where randomization to edoxaban demonstrated a hazard ratio of 0.88 for the primary efficacy endpoint of stroke or systemic embolism, and this did not reach physical significance.

just so the listeners know roughly what they're going to get here, you're a full-time comedian now.

A few years ago, suffered a brain haemorrhage that very easily could have took your life, which was a turning point for you.

And prior to that, to say that you had a colourful life...

Car dealer, career criminal, father of three, husband...